Peter D. Le

Array ( [id] => 4236452 [patent_doc_number] => 06136040 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-24 [patent_title] => 'Animal model with disrupted FGF-9 gene' [patent_app_type] => 1 [patent_app_number] => 9/256546 [patent_app_country] => US [patent_app_date] => 1999-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 4045 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/136/06136040.pdf [firstpage_image] =>[orig_patent_app_number] => 256546 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4404076 [patent_doc_number] => 06299858 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-09 [patent_title] => 'Methods of screening agents for activity using teleosts' [patent_app_type] => 1 [patent_app_number] => 9/255397 [patent_app_country] => US [patent_app_date] => 1999-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 22 [patent_no_of_words] => 32782 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 177 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/299/06299858.pdf [firstpage_image] =>[orig_patent_app_number] => 255397 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1164824 [patent_doc_number] => 06756227 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-06-29 [patent_title] => 'Porcine retrovirus' [patent_app_type] => B1 [patent_app_number] => 09/171553 [patent_app_country] => US [patent_app_date] => 1999-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 6 [patent_no_of_words] => 19257 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/756/06756227.pdf [firstpage_image] =>[orig_patent_app_number] => 09171553 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4371342 [patent_doc_number] => 06274788 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-14 [patent_title] => 'Bicistronic DNA construct comprising X-myc transgene for use in production of transgenic animal model systems for human hepatocellular carcinoma and transgenic animal model systems so produced' [patent_app_type] => 1 [patent_app_number] => 9/243282 [patent_app_country] => US [patent_app_date] => 1999-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 12 [patent_no_of_words] => 4539 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 145 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/274/06274788.pdf [firstpage_image] =>[orig_patent_app_number] => 243282 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1059443 [patent_doc_number] => 06852533 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-02-08 [patent_title] => 'Purified populations of stem cells' [patent_app_type] => utility [patent_app_number] => 09/236729 [patent_app_country] => US [patent_app_date] => 1999-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9143 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/852/06852533.pdf [firstpage_image] =>[orig_patent_app_number] => 09236729 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1216681 [patent_doc_number] => 06706682 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-03-16 [patent_title] => 'Uses of vascular endothelial growth factor in the treatment of erectile dysfunction' [patent_app_type] => B2 [patent_app_number] => 09/234591 [patent_app_country] => US [patent_app_date] => 1999-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8928 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/706/06706682.pdf [firstpage_image] =>[orig_patent_app_number] => 09234591 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1535805 [patent_doc_number] => 06337192 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-08 [patent_title] => 'MMSC1-an MMAC1 interacting protein' [patent_app_type] => B1 [patent_app_number] => 09/233086 [patent_app_country] => US [patent_app_date] => 1999-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 33315 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/337/06337192.pdf [firstpage_image] =>[orig_patent_app_number] => 09233086 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4421144 [patent_doc_number] => 06194634 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-27 [patent_title] => 'Apt-sensitive potassium channel gene-defective animals' [patent_app_type] => 1 [patent_app_number] => 9/213864 [patent_app_country] => US [patent_app_date] => 1998-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 11 [patent_no_of_words] => 6187 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/194/06194634.pdf [firstpage_image] =>[orig_patent_app_number] => 213864 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6261812 [patent_doc_number] => 20020187946 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-12 [patent_title] => 'MAMMALIAN IAP GENE FAMILY, PRIMERS, PROBES AND DETECTION METHODS' [patent_app_type] => new [patent_app_number] => 09/201936 [patent_app_country] => US [patent_app_date] => 1998-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 61 [patent_figures_cnt] => 61 [patent_no_of_words] => 17519 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20020187946.pdf [firstpage_image] =>[orig_patent_app_number] => 09201936 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4234983 [patent_doc_number] => 06135942 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-24 [patent_title] => 'Nucleic acids proteins of a D. melanogaster insulin-like gene and uses thereof' [patent_app_type] => 1 [patent_app_number] => 9/201226 [patent_app_country] => US [patent_app_date] => 1998-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 44163 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/135/06135942.pdf [firstpage_image] =>[orig_patent_app_number] => 201226 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4410476 [patent_doc_number] => 06239267 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-29 [patent_title] => 'VANILREP1 polynucleotides and VANILREP1 polypeptides' [patent_app_type] => 1 [patent_app_number] => 9/197636 [patent_app_country] => US [patent_app_date] => 1998-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 14975 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/239/06239267.pdf [firstpage_image] =>[orig_patent_app_number] => 197636 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4101265 [patent_doc_number] => 06066626 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-23 [patent_title] => 'Compositions and method for treating lysosomal storage disease' [patent_app_type] => 1 [patent_app_number] => 9/182245 [patent_app_country] => US [patent_app_date] => 1998-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 25 [patent_no_of_words] => 8344 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/066/06066626.pdf [firstpage_image] =>[orig_patent_app_number] => 182245 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7640436 [patent_doc_number] => 06395477 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-28 [patent_title] => 'Human potassium channel polynucleotide and polypeptides and uses thereof' [patent_app_type] => B1 [patent_app_number] => 09/178109 [patent_app_country] => US [patent_app_date] => 1998-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 10048 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/395/06395477.pdf [firstpage_image] =>[orig_patent_app_number] => 09178109 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4274936 [patent_doc_number] => 06323330 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-27 [patent_title] => 'Protein C16 and C16N or genes encoding the same' [patent_app_type] => 1 [patent_app_number] => 9/171710 [patent_app_country] => US [patent_app_date] => 1998-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 18415 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/323/06323330.pdf [firstpage_image] =>[orig_patent_app_number] => 171710 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1507788 [patent_doc_number] => 06440944 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-08-27 [patent_title] => 'Methods of administering adenoviral vectors' [patent_app_type] => B2 [patent_app_number] => 09/174508 [patent_app_country] => US [patent_app_date] => 1998-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3781 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 134 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/440/06440944.pdf [firstpage_image] =>[orig_patent_app_number] => 09174508 [rel_patent_id] =>[rel_patent_doc_number] =>)